In selection criteria based on morphokinetic analysis, it has been proposed that an embryo ought to show a certain kinetic division in order to be considered normal (types A and B, in line with ASEBIR criteria). But what happens when an embryo does not fulfil this criteria due to accelerated embryonic development with over 10 cells on day 3?
IB Biotech, the biotechnology and genetics company which is part of the Instituto Bernabeu group, has launched a renewed version of its website, www.ibbiotech.com. The webpage is an alternative means of bringing investigation on genetics closer to society as a whole through intuitive browsing which is accessible from any device.
The new Instituto Bernabeu Group newsletter is now available, dedicated to our last achievements on research & development.
The Ministry of Economy and Competitiveness has awarded Instituto Bernabeu the title of Innovative Company which is given to companies with a proven track record in innovation and in their ability to be innovative in R&D work.
Thank you for your interest in our institution. We will contact you soon to confirm your request.
If you prefer to contact us by phone, please call:
+34 965 50 40 00